Cutting through the noise: How biopharma is actually using AI to scale oncology research
5 Questions every urology practice should ask before selecting an EHR
ESMO 2026: Three key takeaways shaping the future of oncology
Garbage in, gospel out: Why trusted AI in RWE starts with trusted data
Applying AI to Solve Problems That Matter: Introducing Flatiron's Agentic Maturity Model
Flatiron Health at ASH: Real-world evidence that reveals the why behind hematology treatment decisions
Crossing borders with real-world evidence: lessons from the elacestrant case
PCOC 2026 Reflections: Closing the gap between treatment innovation and the point of care
External control arms for emerging biopharma: building credible comparative evidence
